Current Ratio of Inmune Bio, Inc. from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
ratio: x
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Inmune Bio, Inc. quarterly Current Ratio in x history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • Inmune Bio, Inc. Current Ratio for the quarter ending 31 Dec 2025 was 3.55x, a 13% increase year-over-year.
Current Ratio, Quarterly (x)
Current Ratio, YoY Quarterly Change (%)

Inmune Bio, Inc. Quarterly Current Ratio (x)

Period Value YoY Chg Change % Date
Q4 2025 3.55x +0.41x +13% 31 Dec 2025
Q3 2025 4.17x +1.58x +61% 30 Sep 2025
Q2 2025 4.2x +1.84x +78% 30 Jun 2025
Q1 2025 2.64x +0.94x +55% 31 Mar 2025
Q4 2024 3.14x +0.98x +45% 31 Dec 2024
Q3 2024 2.59x -0.58x -18% 30 Sep 2024
Q2 2024 2.36x -1.67x -41% 30 Jun 2024
Q1 2024 1.71x -3.82x -69% 31 Mar 2024
Q4 2023 2.16x -3.76x -63% 31 Dec 2023
Q3 2023 3.18x -6.49x -67% 30 Sep 2023
Q2 2023 4.03x -26.84x -87% 30 Jun 2023
Q1 2023 5.53x -18.36x -77% 31 Mar 2023
Q4 2022 5.92x -13.03x -69% 31 Dec 2022
Q3 2022 9.67x -9.24x -49% 30 Sep 2022
Q2 2022 30.87x +16.14x +109% 30 Jun 2022
Q1 2022 23.89x +1.48x +6.6% 31 Mar 2022
Q4 2021 18.95x +5.44x +40% 31 Dec 2021
Q3 2021 18.9x +1.17x +6.6% 30 Sep 2021
Q2 2021 14.74x +9.51x +182% 30 Jun 2021
Q1 2021 22.41x +16.16x +259% 31 Mar 2021
Q4 2020 13.51x +2.42x +22% 31 Dec 2020
Q3 2020 17.73x +0.89x +5.3% 30 Sep 2020
Q2 2020 5.22x -15.73x -75% 30 Jun 2020
Q1 2020 6.25x 31 Mar 2020
Q4 2019 11.09x +10.06x +975% 31 Dec 2019
Q3 2019 16.84x 30 Sep 2019
Q2 2019 20.96x 30 Jun 2019
Q4 2018 1.03x 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.